131 related articles for article (PubMed ID: 26223374)
21. Treatment of porokeratosis of mibelli with combined use of photodynamic therapy and Fluorouracil cream.
Levitt J; Emer JJ; Emanuel PO
Arch Dermatol; 2010 Apr; 146(4):371-3. PubMed ID: 20404225
[No Abstract] [Full Text] [Related]
22. Disseminated superficial porokeratosis after autologous bone marrow transplantation.
Rio B; Magana C; Le Tourneau A; Bachmeyer C; Lévy V; Hamont N; Diebold J; Zittoun R
Bone Marrow Transplant; 1997 Jan; 19(1):77-9. PubMed ID: 9012935
[TBL] [Abstract][Full Text] [Related]
23. Eruptive disseminated porokeratosis following bone marrow transplantation for acute lymphoblastic leukemia in a child.
Pini M; Balice Y; Tavecchio S; Crippa D
J Dermatol; 2012 Apr; 39(4):403-4. PubMed ID: 21951065
[No Abstract] [Full Text] [Related]
24. Successful treatment of perianal warts in a child with 5% imiquimod cream.
Gruber PC; Wilkinson J
J Dermatolog Treat; 2001 Dec; 12(4):215-7. PubMed ID: 12241631
[TBL] [Abstract][Full Text] [Related]
25. Photodynamic therapy and imiquimod immunotherapy for basal cell carcinomas.
Nikkels AF; Piérard-Franchimont C; Nikkels-Tassoudji N; Bourguignon R; Piérard GE
Acta Clin Belg; 2005; 60(5):227-34. PubMed ID: 16398319
[TBL] [Abstract][Full Text] [Related]
26. Superficial shaving combined with photodynamic therapy for treating disseminated superficial actinic porokeratosis: A case report.
Huang K; Jiang Z; Zeng W; Li Y; Zhang J; Chen M; Zhao S
Photodiagnosis Photodyn Ther; 2019 Sep; 27():24-26. PubMed ID: 31055089
[No Abstract] [Full Text] [Related]
27. Improved effect on 2 cases of disseminated superficial actinic porokeratosis with daylight photodynamic therapy.
Ferrer Guillén B; Giácaman MM; Pérez Ferriols A
Photodiagnosis Photodyn Ther; 2018 Sep; 23():365-366. PubMed ID: 30076993
[No Abstract] [Full Text] [Related]
28. Disseminated superficial actinic porokeratosis treated effectively with topical imiquimod 5% cream.
Arun B; Pearson J; Chalmers R
Clin Exp Dermatol; 2011 Jul; 36(5):509-11. PubMed ID: 21507038
[TBL] [Abstract][Full Text] [Related]
29. Dermatologists, imiquimod, and treatment of molluscum contagiosum in children: righting wrongs.
Katz KA
JAMA Dermatol; 2015 Feb; 151(2):125-6. PubMed ID: 25587702
[No Abstract] [Full Text] [Related]
30. Efficacy of acitretin for porokeratosis in a child with chronic cutaneous graft versus host disease.
Borroni RG; Poddighe D; Zecca M; Brazzelli V
Pediatr Dermatol; 2013; 30(1):148-50. PubMed ID: 22085032
[TBL] [Abstract][Full Text] [Related]
31. Novel dermatologic uses of the immune response modifier imiquimod 5% cream.
Berman B; Poochareon VN; Villa AM
Skin Therapy Lett; 2002 Nov; 7(9):1-6. PubMed ID: 12548325
[TBL] [Abstract][Full Text] [Related]
32. Segmental porokeratosis responding to methyl aminolevulinate photodynamic therapy.
Lecamwasam K; Skellett AM; Levell NJ
Clin Exp Dermatol; 2020 Jun; 45(4):534-536. PubMed ID: 32212271
[No Abstract] [Full Text] [Related]
33. Imiquimod 5% cream for the treatment of actinic keratoses.
Somani N; Rivers JK
Skin Therapy Lett; 2005 Mar; 10(2):1-6. PubMed ID: 15986078
[TBL] [Abstract][Full Text] [Related]
34. Porokeratosis of Mibelli: a new indication for photodynamic therapy?
Gutiérrez Paredes E; Bella Navarro R; Montesinos Villaescusa E; Jordá Cuevas E
Actas Dermosifiliogr; 2013 Apr; 104(3):259-61. PubMed ID: 23102435
[No Abstract] [Full Text] [Related]
35. Segmental porokeratosis after radiation therapy for follicular lymphoma.
James AJ; Clarke LE; Elenitsas R; Katz K
J Am Acad Dermatol; 2008 Feb; 58(2 Suppl):S49-50. PubMed ID: 18191708
[No Abstract] [Full Text] [Related]
36. Successful treatment of disseminated superficial actinic porokeratosis with methyl aminolevulinate-photodynamic therapy.
Cavicchini S; Tourlaki A
J Dermatolog Treat; 2006; 17(3):190-1. PubMed ID: 16854765
[No Abstract] [Full Text] [Related]
37. Lmax and imiquimod 3.75% in daily clinical practice.
Gupta G
J Eur Acad Dermatol Venereol; 2015 Jan; 29 Suppl 1():15-8. PubMed ID: 25470720
[TBL] [Abstract][Full Text] [Related]
38. Randomized, double-blind clinical trial of topical imiquimod 5% with parenteral meglumine antimoniate in the treatment of cutaneous leishmaniasis in Peru.
Miranda-Verástegui C; Llanos-Cuentas A; Arévalo I; Ward BJ; Matlashewski G
Clin Infect Dis; 2005 May; 40(10):1395-403. PubMed ID: 15844060
[TBL] [Abstract][Full Text] [Related]
39. New and emerging treatments for nonmelanomas and actinic keratoses.
Peterson SR; Goldberg LH
J Drugs Dermatol; 2003 Aug; 2(4):429-32. PubMed ID: 12884470
[No Abstract] [Full Text] [Related]
40. Treatment of actinic keratoses with 5% topical imiquimod: a multicenter prospective observational study from 93 Austrian office-based dermatologists.
Strohal R; Kerl H; Schuster L
J Drugs Dermatol; 2012 May; 11(5):574-8. PubMed ID: 22527424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
